The latest expert opinions on the Novo Nordisk share at an overview.
The Novo Nordisk share was analyzed by 12 experts in July 2025.
8 Analysts recommend the Novo Nordisk share with buying, 4 experts recommend keeping the Novo Nordisk share.
The average price target of the analysts is 622.92 DKK, which corresponds to an expected increase of 297.92 DKK to the current CPH stand of the Novo Nordisk share of 325.00 DKK.
The 6-month rating trend is up to buy.
| Analyst | Price target | Distance target | Date | |
|---|---|---|---|---|
| Barclays Capital | 375.00 DKK | 15.38 | 07/30/2025 | |
| JP Morgan Chase & Co. | 500.00 DKK | 53.85 | 07/30/2025 | |
| Amber research | 620.00 DKK | 90.77 | 07/30/2025 | |
| DZ Bank | – | – | 07/29/2025 | |
| JP Morgan Chase & Co. | 650.00 DKK | 100.00 | 07/29/2025 | |
| Amber research | 620.00 DKK | 90.77 | 07/28/2025 | |
| UBS AG | 600.00 DKK | 84.62 | 07/18/2025 | |
| Deutsche Bank AG | 750.00 DKK | 130.77 | 07/18/2025 | |
| UBS AG | 600.00 DKK | 84.62 | 07/16/2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 610.00 DKK | 87.69 | 07/15/2025 | |
| UBS AG | 700.00 DKK | 115.38 | 07/11/2025 | |
| Deutsche Bank AG | 750.00 DKK | 130.77 | 07.07.2025 | |
| UBS AG | 700.00 DKK | 115.38 | 03.07.2025 | |
| UBS AG | – | – | 01.07.2025 |
Editor finance.net
Selected leverage products on Novo Nordisk
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Novo Nordisk
The lever must be between 2 and 20
Advertising